Nartel suspension, containing artemether and lumefantrine, is indicated for the treatment of uncomplicated malaria; it is contraindicated in patients with a known hypersensitivity to the components, may cause side effects such as headache, dizziness, and gastrointestinal disturbances, and can interact with drugs that affect cytochrome P450 enzymes, potentially altering the metabolism of either medication.